Shu Wang, MD, PhD
Phone: (806) 834-4050
Fax: (806) 742-2926
Room: HS 279
Department of Nutritional Sciences
Dr. Wang's research assesses the interplay between diet and chronic diseases, including obesity and cardiovascular disease, and she is a pioneer in using biocompatible and biodegradable nanocarriers to enhance bioactivities of phytochemicals and nutrients to prevent and treat these diseases. Dr. Wang's group focuses on targeted delivery of natural bioactive compounds to disease tissues or cells using biodegradable and biocompatible nanoparticles as carriers, which can increase their solubility, stability, payload, and cellular bioavailability, lower their toxicity, prolong their circulation time, and target them to specific cells or tissues for the prevention and treatment of chronic diseases. She has been funded by a variety of federal, industry and foundation agencies, especially three competitive NIH awards. Since 2009, she has published more than forty peer-reviewed articles and four book chapters. Dr. Shu Wang has received several research honors to recognize the quality of her research. This includes 2014 Chancellor's Council Distinguished Research Award in the Texas Tech University system, and 2017 Mary Swartz Rose Young Investigator Award from American Society for Nutrition. Dr. Wang is a member of the Journal of Nutritional Biochemistry editorial board. She serves in grant review panels of NIH and American Heart Association. Currently, she serves as a president of the North America Chinese Society for Nutrition (NACSN) this year.
Dr. Wang's Nutrition and Nanomedicine Laboratory
Ph.D. in Nutritional Biochemistry and Metabolism, Tufts University, Medford, MA
M.S. in Biochemistry and Molecular Biology, Capital Medical University, Beijing, China
Bachelor of Medicine, Norman Bethune University of Medical Sciences, Changchun, China
- NS6340 Nutrition and Chronic Diseases
- NS5370 Carbohydrates, Lipids and Proteins in Nutrition
- Zhang J, Nie S, Zu Y, Abbasi M, Cao J, Li C, Wu D, Labib S, Brackee G, Shen CL, Wang S. Anti-atherogenic effects of CD36-targeted epigallocatechin gallate-loaded nanoparticles. J Control Release. 2019; 303:263-273.
- Zu Y, Overby H, Ren G, Fan ZY, Zhao L, Wang S. Resveratrol liposomes and lipid nanocarriers: comparison of characteristics and inducing browning of white adipocytes. Colloids Surf B Biointerfaces. 2018;164: 414-423.
- Zhang J, Nie S, Martinez-Zaguilan R, Sennoune S, Wang S. Formulation, Characteristics and Anti-atherogenic Bioactivities of CD36-Targeted Epigallocatechin Gallate (EGCG)-Loaded Nanoparticles. J Nutr Biochem. 2016;30:14–23. NIHMS 740685.
- Nie S, Zhang J, Martinez-Zaguilan R, Sennoune S, Hossen MN, Lichtenstein AH, Cao J, Meyerrose GE, Paone R, Soontrapa S, Fan Z, Wang S. Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles. J Control Release. 2015; 220:61-70. NIHMS732821.
- Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, Bapat P, Kwun IS, Shen CL. Novel Insights of Dietary Polyphenols and Obesity. J Nutr Biochem. 2014; 25(1):1-18.